[Lambert-Eaton myasthenic syndrome].
Sakai
K
K
Department of Neurology, Kanazawa Medical University.
D000818:Animals; D015551:Autoimmunity; D015220:Calcium Channels / Q000276:immunology; D002135:Calcium-Binding Proteins; D018288:Carcinoma, Small Cell / Q000150:complications / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D007074:Immunoglobulin G; D015624:Lambert-Eaton Myasthenic Syndrome / Q000209:etiology / Q000503:physiopathology; D008175:Lung Neoplasms / Q000150:complications / Q000628:therapy; D008562:Membrane Glycoproteins / Q000276:immunology; D009419:Nerve Tissue Proteins / Q000276:immunology; D009469:Neuromuscular Junction; D011379:Prognosis; D050857:Synaptotagmins
D015220:Calcium Channels; D002135:Calcium-Binding Proteins; D007074:Immunoglobulin G; D008562:Membrane Glycoproteins; D009419:Nerve Tissue Proteins; D050857:Synaptotagmins